T15	Exp 39 43	that
T16	Exp 137 172	the immune or inflammation response
T17	Exp 184 204	the adhesion process
T18	Exp 288 289	I
T19	Exp 273 286	its inhibitor
T20	Exp 339 352	the cytoplasm
T21	Exp 390 391	I
T22	Exp 463 465	it
T23	Exp 476 492	its target genes
T24	Exp 457 462	where
T25	Exp 444 455	the nucleus
T26	Exp 533 534	I
T27	Exp 520 524	that
T28	Exp 494 519	The transduction pathways
T29	Exp 596 598	we
T30	Exp 685 689	that
T31	Exp 637 660	the 70/Z3-derived 1.3E2
T32	Exp 584 594	this study
T33	Exp 750 752	We
T34	Exp 883 897	I kappaB alpha
T35	Exp 765 769	that
T36	Exp 1012 1026	I kappaB alpha
T37	Exp 1058 1080	the two major subunits
T38	Exp 1097 1111	this cell line
T39	Exp 1126 1153	this phosphorylation defect
T40	Exp 990 1008	Neither a mutation
T41	Exp 1214 1228	I kappaB alpha
T42	Exp 1267 1271	that
T43	Exp 1181 1210	the inducible phosphorylation
T44	Exp 1255 1266	the stimuli
T45	Exp 1325 1368	the antioxidant pyrrolidine dithiocarbamate
T46	Exp 1496 1510	I kappaB alpha
T47	Exp 1452 1457	which
T48	Exp 1545 1561	the redox status
T49	Exp 1624 1626	We
T50	Exp 1639 1643	that
T51	Exp 1768 1772	that
T52	Exp 1644 1690	the human T-cell leukemia virus type 1 (HTLV-1
T53	Exp 1813 1834	the defective pathway
T54	Exp 1773 1791	this viral protein
T55	Exp 1845 1847	we
T56	Exp 1862 1886	other I kappaB molecules
T57	Exp 1888 1901	I kappaB beta
T58	Exp 1906 1946	the recently identified I kappaB epsilon
T59	Exp 1853 1857	that
T60	Exp 1968 2009	the 1.3E2 cell line following stimulation
T61	Exp 2011 2022	Our results
T62	Exp 2035 2039	that
T63	Exp 2110 2114	that
T64	Exp 2268 2282	I kappaB alpha
T65	Exp 2284 2297	I kappaB beta
T66	Exp 2303 2319	I kappaB epsilon
T67	Exp 2255 2259	that
T68	Exp 2232 2254	the signaling pathways
T69	Exp 2192 2205	this analysis
R11	Coref Anaphora:T15 Antecedent:T70
R12	Coref Anaphora:T19 Antecedent:T71
R13	Coref Anaphora:T24 Antecedent:T25
R14	Coref Anaphora:T22 Antecedent:T25
R15	Coref Anaphora:T23 Antecedent:T25
R16	Coref Anaphora:T27 Antecedent:T28
R17	Coref Anaphora:T30 Antecedent:T72
R18	Coref Anaphora:T42 Antecedent:T44
R19	Coref Anaphora:T47 Antecedent:T73
R20	Coref Anaphora:T54 Antecedent:T6
R21	Coref Anaphora:T63 Antecedent:T74
R22	Coref Anaphora:T67 Antecedent:T68
T1	Protein 883 897	I kappaB alpha
T2	Protein 1012 1026	I kappaB alpha
T3	Protein 1045 1048	p50
T4	Protein 1052 1056	relA
T5	Protein 1214 1228	I kappaB alpha
T6	Protein 1496 1510	I kappaB alpha
T7	Protein 1700 1703	Tax
T8	Protein 1888 1901	I kappaB beta
T9	Protein 1930 1946	I kappaB epsilon
T10	Protein 2268 2282	I kappaB alpha
T11	Protein 2284 2297	I kappaB beta
T12	Protein 2303 2319	I kappaB epsilon
T70	Exp 20 38	a mutant cell line
T71	Exp 0 16	Characterization
T72	Exp 661 683	murine pre-B cell line
T73	Exp 1428 1450	phosphatase inhibitors
T74	Exp 2103 2109	a step
